Last Week in Psychedelic Sundays

in #psychedelics5 years ago

image.png

There is a wealth of information built into us ... tucked away in the genetic material in every one of our cells ... without some means of access, there is no way even to begin to guess at the extent and quality of what is there. The psychedelic drugs allow exploration of this interior world, and insights into its nature.
-Alexander Shulgin

In this post, I will share with you some of what I found on my neverending journey through the psychedelic digital jungle of interesting articles, podcasts, and studies that I have found.

image.png


Psychedelics Decrim Activists Mark First Anniversary Of Denver’s Historic Psilocybin Mushroom Vote

The Decriminalize Denver campaign defied odds and expectations. Psilocybin was just entering into the mainstream lexicon, there weren’t any large and monied psychedelics advocacy groups chipping in and voter confusion about what it meant to decriminalize—rather than allow retail sales like is the case for marijuana—threatened to derail the bold initiative.

Montana Marijuana Activists Will Begin Signature Gathering For Legalization Measure With New Safety Protocols

Montana activists announced on Thursday that they will proceed with a signature gathering drive for a marijuana legalization initiative, and they laid out multiple internal policies that will be in place to protect circulators and the public during the coronavirus pandemic.

Maryland: Governor Vetoes Bill Shielding Marijuana-Related Convictions from Public View

Republican Gov. Larry Hogan has vetoed legislation, House Bill 83, which sought to prohibit “the Maryland Judiciary Case Search from in any way referring to the existence of a certain case in which possession of marijuana is the only charge in the case and the charge was disposed.” The database provides public access to the case records of the Maryland Judiciary.

POLITICSNew Zealand Government Unveils Final Marijuana Legalization Measure For 2020 Ballot

Early details about the measure were released in December. And on Friday, the government shared the full proposal, which would make it legal for adults 20 and older to purchase and possess cannabis, cultivate two plants for personal use and visit marijuana “coffee shops” where on-site consumption would be allowed. Individuals would be able to purchase up to 14 grams of cannabis from licensed retailers and also gift up to 14 grams to another adult.

Europeans Are Relying on Darknet Weed to Stock Up During COVID-19 Lockdowns

Recreational marijuana remains illegal throughout most of the EU. And since most street dealers don’t want to risk getting sick with the coronavirus, that leaves consumers stuck with buying weed via the darknet.

Amid COVID-19 Lockdown, Psychedelic Reform Campaigns Go Digital

On Tuesday, Marijuana Moment reported that the Council unanimously approved emergency legislation that would allow ballot initiative campaigns to distribute their petitions electronically and therefore remotely gather signatures. Although voters would still have to physically sign printed sheets, they would be able to scan them and send them back to the campaign headquarters. The new legislation would also allow ballot petitioners to sign their own petitions (until this point, they instead have had to sign one controlled to a separate voter, which is made more difficult due to quarantine orders).

Ketamine Clinics Los Angeles Deemed 'Essential' Business During COVID-19 Pandemic

Ketamine Clinics Los Angeles (KCLA), a leading mental health clinic that provides IV ketamine infusions to treat mood disorders and chronic pain, is keeping its state-of-the-art facility open amid the coronavirus (COVID-19) pandemic. As the leading ketamine clinic in the United States, KCLA has set the gold standard for maintaining high-quality care and overall safety for patients and staff, including many additional precautions at this time; its website details those pandemic-specific precautions.

image.png


The Psychedelic Research Hiatus And Its Relevance Today

The path forward must consider all facts at hand and build on honesty, not only with regard to potential medical findings and adverse reactions. Cherry picking, even in the field of historiography, is unlikely to be fruitful in the long run for the growing field of research into the therapeutic potentials of psychedelics.

Will Psilocybin Clinics Be The Next Big Thing In Treating Depression?

Earlier this year we wrote about the movement to decriminalize psilocybin – noting its success in Denver, Oakland, and Santa Cruz – and that nearly 100 other cities are looking at decriminalizing psychedelics. (The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)). That article posited that psilocybin would move along two tracks similar to cannabis (medical and pharmaceutical) before approaching the “retail model” initiatives that became standard with adult use cannabis.

Entheon Biomedical Announces Private Placement to Begin Pre-clinical Trials with Psychedelic Compounds DMT & 5 MEO DMT

Entheon Biomedical is a psychedelic R&D company investing in research and an intensive drug discovery program with the aim to commercialize a portfolio of psychedelic therapies specifically designed for the treatment of addictive disorders. Psychedelics have a long history in the treatment of addictive disorders, and we are all very excited to be working alongside a growing community of scientists and medical professionals to dispel and overcome the many misconceptions with respect to the clinical use of psychedelics.

Research News Tip Sheet: Story Ideas From Johns Hopkins

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.

NeonMind and Translational Life Sciences to Design Psilocybin Mushroom Clinical Trials

According to the terms of the engagement, signed on May 6, 2020, NeonMind and TLS shall work together to conduct the evaluation of psilocin or psilocybin on cravings, on the metabolism, on food addiction and on glucose and hormone levels. Neon authorizes TLS to perform activities required to prepare for and conduct the study and the parties shall work towards entering into a clinical study agreement. NeonMind shall pay for all costs related to the study and TLS shall arrange for prior approval by Health Canada, and engagement of all necessary parties to conduct the study.

image.png


Mazatec Perspectives on the Globalization of Psilocybin Mushrooms

This article is the result of conversations not only between its authors but also with Mazatec friends in the region, who have at different times expressed their concern about the “little ones who sprout from the earth,” especially in the face of an emergent psychedelic capitalism: To them we give our respects.

THE 17 BEST FILMS ABOUT MDMA AND ECSTASY

MDMA and, in pill form, ecstasy is intertwined with dance music and rave culture. Partake or not, a Big Night Out on E with your best mates listening to your favourite DJs is one of the main dance music tropes, something that countless people have done that's taken on a mythical quality thanks to it being a shared experience which usually results in some kind of epiphany (brief, long lasting or otherwise) along the way.

Netflix And Trip: Take A Psychedelic Adventure In This Star-Studded Documentary

“I don’t think psychedelics are the answers to the world’s problems,” Sting shares in the trailer for the new Netflix documentary Have a Good Trip: Adventures in Psychedelics. “But they could be a start.”

"There's no doubt that it can be incredibly effective in healing all manner of conditions." 1091 Media has unveiled an official trailer for a documentary called The Medicine, which is a new film about the infamous hallucinogenic plant known as Ayahuasca. Here's the official trailer (+ poster) for Farzin Toussi's doc The Medicine:

image.png